Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median.
Ontology highlight
SUBMITTER: Messori A
PROVIDER: S-EPMC7271675 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA